Friday, October 23, 2009

Carcinoid Syndrome

Neuroendocrine
Serotonine (5-HT), et al. Vasoactive substances (e.g. Kallikrein)
Tumors expressing Somatostatin receptors

3 comments:

  1. Endothelial Effects (5HT2B receptors):
    1. Cardiac: R+ Heart TS, PF
    2. Vascular:
    3. Skin: Flushing (kallikrein)

    GIT:
    1. Diarrhea (5-HT)
    2. Pellagra* (Diversion of Tryptophan from Niacin/B-3 to 5-HT)
    3. Symptoms in CS follow metastases to Liver**

    ** products usually systemically inactivated by MAO

    ReplyDelete
  2. Kallikrein-> Bradykinin->Vasodilation

    ReplyDelete
  3. Rx:
    1. Surgical Excision
    2. Octreotide (Somatostatin inhibitor)

    ReplyDelete